This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DSM-Firmenich 미래 성장

Future 기준 확인 4/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for DSM-Firmenich.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Chemicals 수익 성장	0%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	31 May 2023

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

LSE:0NPP - 애널리스트의 미래 추정치 및 과거 재무 데이터 ( )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2022	8,390	454	314	965	N/A
9/30/2022	9,582	837	412	1,056	N/A
6/30/2022	9,802	1,082	510	1,147	N/A
3/31/2022	9,503	1,081	680	1,287	N/A
12/31/2021	7,269	820	850	1,427	N/A
9/30/2021	7,955	660	884	1,507	N/A
6/30/2021	7,558	493	906	1,489	N/A
3/31/2021	7,572	423	906	1,497	N/A
12/31/2020	8,106	448	868	1,494	N/A
9/30/2020	7,960	510	809	1,434	N/A
6/30/2020	8,034	557	810	1,462	N/A
3/31/2020	9,011	722	826	1,471	N/A
12/31/2019	7,998	675	744	1,385	N/A
9/30/2019	8,272	820	766	1,399	N/A
6/30/2019	8,502	794	747	1,395	N/A
3/31/2019	9,124	934	612	1,282	N/A
12/31/2018	9,267	1,069	698	1,391	N/A
9/30/2018	9,235	984	657	1,310	N/A
6/30/2018	9,106	2,082	550	1,170	N/A
3/31/2018	8,908	1,942	512	1,110	N/A
12/31/2017	8,632	1,761	441	996	N/A
9/30/2017	8,471	1,676	431	993	N/A
6/30/2017	8,333	738	470	1,028	N/A
3/31/2017	8,166	711	554	1,077	N/A
12/31/2016	7,920	645	523	1,018	N/A
9/30/2016	7,831	588	N/A	958	N/A
6/30/2016	7,778	274	N/A	914	N/A
3/31/2016	7,749	214	N/A	811	N/A
12/31/2015	7,722	174	N/A	696	N/A
9/30/2015	7,607	66	N/A	800	N/A
6/30/2015	7,456	114	N/A	820	N/A
3/31/2015	7,245	115	N/A	867	N/A
12/31/2014	7,051	123	N/A	808	N/A
9/30/2014	7,415	112	N/A	866	N/A
6/30/2014	7,834	138	N/A	885	N/A
3/31/2014	8,362	182	N/A	1,010	N/A
12/31/2013	8,858	252	N/A	998	N/A
9/30/2013	8,409	363	N/A	705	N/A
6/30/2013	8,500	335	N/A	638	N/A
3/31/2013	8,486	257	N/A	584	N/A
12/31/2012	8,588	280	N/A	730	N/A
9/30/2012	9,089	453	N/A	950	N/A
6/30/2012	9,107	543	N/A	1,020	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 0NPP's forecast earnings growth (20.5% per year) is above the savings rate (1.2%).

수익 vs 시장: 0NPP's earnings (20.5% per year) are forecast to grow faster than the UK market (8.9% per year).

고성장 수익: 0NPP's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: 0NPP's revenue (11.1% per year) is forecast to grow faster than the UK market (5.2% per year).

고성장 수익: 0NPP's revenue (11.1% per year) is forecast to grow slower than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: Insufficient data to determine if 0NPP's Return on Equity is forecast to be high in 3 years time

This company listing is no longer active

DSM-Firmenich 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Koninklijke DSM N.V. Reaffirms Earnings Guidance for the Year 2022

DSM Suspends Overall Earnings Outlook for the Full Year 2020

Recent updates

DSM-Firmenich AG has completed a Follow-on Equity Offering in the amount of €733.264232 million.

Key Executive recently sold €438k worth of stock

Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)

DSM Firmenich Announces Intention Pay Final Gross Dividend

Key Executive recently bought €587k worth of stock

Royal DSM NV Sponsored ADR to Be Deleted from OTC Equity

Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023

Avient Corporation (NYSE:AVNT) completed the acquisition of Protective Materials business of Koninklijke DSM N.V. (ENXTAM:DSM)

First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)

Koninklijke DSM N.V. Announces Interim Dividend

Koninklijke DSM N.V. (ENXTAM:DSM) agrees to acquire Prodap Participacoes S/A.

Advent International Corporation and LANXESS Aktiengesellschaft (XTRA:LXS) agreed to acquire Engineering Materials business of Royal DSM from Koninklijke DSM N.V. (ENXTAM:DSM) for €3.9 billion.

Investor sentiment improved over the past week

Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 June 2022

Public Joint Stock Company KuibyshevAzot (MISX:KAZT) acquired Volgaplast Compounding Ltd from Koninklijke DSM N.V. (ENXTAM:DSM) for RUB119 million.

Upcoming dividend of €1.70 per share

Koninklijke DSM N.V. Reaffirms Earnings Guidance for the Year 2022

Avient Corporation (NYSE:AVNT) entered into agreement to acquire Protective Materials business of Koninklijke DSM N.V. (ENXTAM:DSM) for €1.4 billion ($1.5 billion).

Avient Corporation (NYSE:AVNT) eneteed into agreement to acquire Protective Materials business of DSM

DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer

Royal DSM Proposes Dividend Increase

Lanxess Reportedly Teams Up with Advent to Bid for DSM's Materials Ops

Koninklijke DSM N.V. (ENXTAM:DSM) completed the acquisition of Vestkorn Milling AS.

Koninklijke DSM N.V. (ENXTAM:DSM) signed an agreement to acquire Vestkorn Milling As for an enterprise value of €65 million.

Koninklijke DSM N.V. Receives First Full Market Authorizations for Methane-Reducing Feed Additive Bovaer® for Beef and Dairy in Brazil and Chile

Independent Deputy Chairwoman of Supervisory Board has left the company

Independent Chairman of Supervisory Board Robert Routs has left the company

Royal DSM Declares Final Dividend for the Financial Year 2020, Payable from 1 June 2021

Upcoming dividend of €1.60 per share

Key Executive recently sold €750k worth of stock

Worthen Industries, Inc. agreed to acquire Advanced Solar Backsheets Business of Koninklijke DSM N.V. from Koninklijke DSM N.V. (ENXTAM:DSM).

Koninklijke Dsm N.V. Announces Board Changes

New 90-day low: €107

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)

Revenue misses expectations

Royal DSM Announces Executive Changes

Valio and Royal Dsm Announces Collaboration Agreement to Develop Sustainable Dairy Products

DSM Suspends Overall Earnings Outlook for the Full Year 2020

Koninklijke DSM N.V. (ENXTAM:DSM) completed the acquisition of ERBER Group from Erber It Service GmbH, San Pacific Investments Pte Ltd. and San Venture Pte. ltd.

Covestro AG (XTRA:1COV) reached an agreement to acquire Resins & Functional Materials and associated businesses from Koninklijke DSM N.V. (ENXTAM:DSM) for purchase price of €1.6 billion.

New 90-day high: €141

Würth Industry North America Signs Agreement with DSM To Nationally Distribute DSM 3D Printing Material Solutions

New 90-day high - €137

New 90-day high - €135

First half earnings released

Koninklijke DSM N.V. to Report Q1, 2021 Results on May 05, 2021

Koninklijke DSM N.V. completed the acquisition of 100% stake in Pocketcoach GmbH.

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견